|Committee Member||Employment||Consultant||Speakers Bureau||Ownership/Partnership/Principal||Personal Research||Institutional, Organizational, or Other Financial Benefit||Expert Witness||Voting Recusals by Section∗|
|Stephan D. Fihn|
|Department of Veterans Affairs—Director, Office of Analytics and Business Intelligence||None||None||None||None||None||None||None|
|James C. Blankenship|
|Geisinger Medical Center—Staff Physician; Director, Cardiac Catheterization Laboratory||None||None||None||None||None||2.2.5|
|Karen P. Alexander||Duke University Medical Center—Associate Professor of Medicine/Cardiology||None||None||None||None||2.2.5|
|John A. Bittl||Munroe Regional Medical Center—Invasive Cardiologist||None||None||None||None||None||None||None|
|John G. Byrne||Brigham and Women’s Hospital—Chief, Division of Cardiac Surgery||None||None||None||None||None||None||None|
|Barbara J. Fletcher||University of North Florida—Clinical Associate Professor, School of Nursing||None||None||None||None||None||None||None|
|Gregg C. Fonarow||UCLA Cardiomyopathy Center—Professor of Medicine||None||None||None||None||None||2.2.5|
|Richard A. Lange||University of Texas Health Science Center, San Antonio—Professor of Medicine||None||None||None||None||None||None||None|
|Glenn N. Levine||Baylor College of Medicine—Professor of Medicine; Director, Cardiac Care Unit||None||None||None||None||None||None||None|
|Thomas M. Maddox||VA Eastern Colorado Health Care System—Cardiologist||None||None||None||None||None||None||None|
|Srihari S. Naidu||Winthrop University Hospital—Director, Cardiac Catheterization Laboratory||None||None||None||None||None||None||None|
|E. Magnus Ohman||Duke Medicine—Professor of Medicine||None||None||None||2.2.5|
|Peter K. Smith||Duke University Medical Center—Professor of Surgery; Chief, Thoracic Surgery||None||None||None||None||None||None||None|
This table represents the relationships of writing group members with industry and other entities that were determined to be relevant to this document. These relationships were reviewed and updated in conjunction with all meetings and/or conference calls of the writing group during the document development process. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$10,000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted.
According to the ACC/AHA, a person has a relevant relationship IF: a) the relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue addressed in the document; or b) the company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device addressed in the document; or c) the person or a member of the person’s household has a reasonable potential for financial, professional, or other personal gain or loss as a result of the issues/content addressed in the document.
AATS indicates American Association for Thoracic Surgery; ACC, American College of Cardiology; AHA, American Heart Association; PCNA, Preventive Cardiovascular Nurses Association; SCAI, Society for Cardiovascular Angiography and Interventions; STS, Society of Thoracic Surgeons; and VA, Veterans Affairs.